Hospital Universitari de Bellvitge clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-20
What changed in the last 30 days
3 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 2 with minor changes only.
- Minor: Subphenotype- and Complication-guided Adjunctive Fosfomycin Therapy for Staphylococcus Aureus Bacteraemia Trial completed
- Notable: RETRO-PELVIS · Systematic Anatomical Description of the Female Pelvic Retroperitoneum in Cadavers Primary completion pushed from Sep 28, 2026 to Sep 28, 2027
- Minor: Impact of the Implementation of a Telemedicine Program on Patients Diagnosed With Asthma Trial completed
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
Active trials by phase
| Phase 4 | 1 |
Not charted: 28 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Disease areas by active trials, top 10 of 12
Breast Cancer (5) · Colorectal Cancer (2) · Obesity (2) · Pancreatic Cancer (2) · Cholangiocarcinoma (1) · Chronic Kidney Disease (1) · COPD (1) · Diabetes (1) · Endometrial Cancer (1) · Esophageal Cancer (1)
Get alerts when Hospital Universitari de Bellvitge's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.